First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer

NCT04974944 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

172

Enrollment

OTHER

Sponsor class

Conditions

Stage IVB Cervical Cancer
Recurrent Cervical Cancer
Persistent Cervical Cancer

Interventions

DRUG: Camrelizumab
DRUG: Apatinib
DRUG: Paclitaxel
DRUG: Cisplatin
DRUG: Carboplatin
DRUG: Bevacizumab

Sponsor

Sun Yat-sen University